Seattle Genetics | SGEN - الربح قبل الضريبة



الربح قبل الضريبة تغيير تاريخ
AbbVie USD 7.61B 2.04B 2026-06
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Amgen USD 2.08B 570M 2026-03
Astellas Pharma JPY 186.51B 138.49B 2026-06
Bayer EUR 321M 2.67B 2026-06
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Celldex Therapeutics USD -78.68M 2.63M 2026-03
Daiichi Sankyo JPY -6.52B 113.25B 2026-03
Eisai JPY 25.28B 33.22B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Genmab DKK 295M 221M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Glaxosmithkline GBP 2.14B 312M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Insmed USD -11.37M 150.72M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD -3.53B 6.95B 2026-03
Moderna USD -1.33B 535M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sanofi EUR 837M 1.17B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Takeda JPY 162.72B 215.2B 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06
Xencor USD -21.92M 106.72M 2026-06